SCHEMBL3503323

SCHEMBL3503323

CNC(=O)Oc1ccc2onc(NCCN3CCOCC3)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 2/20 0.45
▸ HSP90AB1 P08238 1/20 0.45
▸ DRD3 P35462 2/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ CYP1A2 P05177 3/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ CLK4 Q9HAZ1 3/20 0.42
▸ USP2 O75604 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ ABL1 P00519 1/20 0.42
▸ BCR P11274 1/20 0.42
▸ CYP2D6 P10635 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ ACHE P22303 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HBB P68871 1/20 0.41
▸ GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504318 0.92 ACHE (0.41) HSP90AA1HSP90AB1ALDH1A1CYP1A2CYP3A4
SCHEMBL3505069 0.87 GAA (0.45) DRD3ALDH1A1HSD17B10LMNAKDM4E
SCHEMBL3504880 0.84 ALDH1A1 (0.56) HSP90AA1HSP90AB1DRD3ALDH1A1CYP1A2
SCHEMBL3504561 0.80 ALDH1A1 (0.46) HSP90AA1HSP90AB1ALDH1A1CYP1A2CYP3A4
SCHEMBL3505856 0.79 EPHX2 (0.42) DRD3ACHEGAATDP1
SCHEMBL6953674 0.79 HSP90AA1 (0.55) HSP90AA1HSP90AB1ALDH1A1CYP1A2CYP3A4
SCHEMBL8183130 0.77 CYP3A4 (0.47) HSP90AA1HSP90AB1ALDH1A1CYP1A2CYP3A4
SCHEMBL6951018 0.77 HRH3 (0.45) DRD3ALDH1A1HSD17B10LMNAKDM4E
SCHEMBL6959886 0.76 ALDH1A1 (0.53) ALDH1A1CYP1A2CYP3A4CLK4USP2
SCHEMBL9085767 0.75 NR1I3 (0.46) HSP90AA1HSP90AB1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US claimed
US-20100247543-A1 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS, S.A. (ES) 2010-09-30 — — US disclosed
EP-0669920-B1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS AVENTIS PHARMA INC (US) 2003-02-12 — — EP disclosed
US-6046203-A USEFUL FOR THE TREATMENT OF VARIOUS MEMORY DYSFUNCTIONS CHARACTERIZED BY A DECREASED CHOLINERGIC FUNCTION SUCH AS ALZHEIMER'S DISEASE; ALSO INHIBIT MONOAMINE OXIDASE AND HENCE ARE USEFUL AS ANTIDEPRESSANTS AVENTIS PHARMACEUTICALS INC. (US) 2000-04-04 — — US disclosed
US-5580982-A ANTIDEPRESSANTS; ANTICHOLINERGIC AGENTS; ALZHEIMER'S DISEASE; AMINE OXIDASE INHIBITORS HOECHST MARION ROUSSEL INC. (US) 1996-12-03 — — US disclosed
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US disclosed
WO-1994012495-A1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1994-06-09 — — WO disclosed
Send feedback